Jinlan 98+ EP/BP/USP Rituximab
1 Inquiries
174722-31-7
medical grade
98%
Shanghai/Ningbo/Qingdao
Jinlan
25kg/Cardboard Drum
2026-04-15
Peptides,API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRituximab, a chimeric murine/human monoclonal antibody approved in the United States only for treating refractory or relapsed B-cell lymphomas, reacts with the CD20 antigen. It contains the complementarity determining murine anti-CD20 antibody 2B8 regions in conjunction with human kappa and IgG1 heavy-chain constant region sequences. The vector was cloned into Chinese hamster ovarian cells as the production source of immunoglobulin. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids with a molecular weight of 145 kD. Rituximab has a binding affinity for the CD20 antigen of approximately 8.0 nM, similar to the parent murine antibody, 2B8[1].Basic Info
-
Product Name:
Rituximab
Other Name:IMMunoglobulin G1,anti-(huMan CD20 (antigen)) (huMan-Mouse Monoclonal IDEC-C2B8 g1-chain), disulfide withhuMan-Mouse Monoclonal IDEC-C2B8 k-chain, diMer;Ig gamma-1 chain C region;Immunoglobulin G1;Hsdb 7455;Immunoglobulin G 1 (human-mouse monoclonal idec-C2B8 gamma1-chain anti-human antigen cd 20), disulfide with human-mouse monoclonal idec-C2B8 kappa-chain, dimer;Mab thera;Mabthera;Rituxan
CAS No.:174722-31-7
Molecular Formula:C6416H9874N1688O1987S44
Molecular Weight:0
Color/Form:Colorless to light yellow
Categories:
Characteristics-
Critical Temperature & Pressure:
Store at -80°C
Hazard IdentificationClassification of the substance or mixture
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P319 Get medical help if you feel unwell.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides,API,Intermediate
-
Location:
Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1
-
Payment Terms:
100% TT in advance
-
Average lead Time:
275
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2020
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Australia
Research Grade Rituximab
5 MG Jun 10, 2026 Post an enquiry for this product
- Hot Searches
- bioglutide peptide for sale
- etoroxib
- where to get sulfur hexafluoride
- dimethylformamide sds
- reta peptide purchase
- hexane 3 4 dione
- eriochrome black t msds
- etorecoxib
- sodium benzoate vs benzoic acid
- best place to buy retatrutide peptides online
- bioglutide for sale
- chemical compound of acetone